Lomustine is an alkylating nitrosourea chemotherapy agent, characterized by its high lipid solubility which allows the drug to cross the blood-brain barrier to treat malignant brain tumors like glioblastoma… Read more




















Lomustine is an alkylating nitrosourea chemotherapy agent, characterized by its high lipid solubility which allows the drug to cross the blood-brain barrier to treat malignant brain tumors like glioblastoma multiforme as well as certain mast cell tumors in veterinary medicine. To support rigorous pharmaceutical quality control and method development, this category provides a range of reference standards. These include pharmacopeial and non-pharmacopeial impurities, such as hydroxy-lomustine stereoisomers and related urea compounds, which are essential for accurate impurity profiling and stability testing. Additionally, the collection offers a selection of stable isotope labelled compounds, such as deuterated lomustine derivatives, which serve as critical internal standards in mass spectrometry-based analytical testing. By utilizing these specific standards, laboratories can ensure the precision of their assay results and maintain compliance with regulatory requirements throughout the drug development lifecycle.